Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists, and oncologists in hundreds of clinics and research centers around the world. The Cortechs.ai team includes scientists, engineers, business professionals, and clinical specialists working towards the common goal of improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers.
Cortechs.ai's flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer's disease, multiple sclerosis, epilepsy and traumatic brain injury.
Cortechs.ai's flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer's disease, multiple sclerosis, epilepsy and traumatic brain injury.
Location: United States, California, San Diego
Employees: 11-50
Founded date: 2001
Mentions in press and media 4
| Date | Title | Description |
| 21.11.2024 | The Surge of Innovation: Distru and Cortechs.ai Secure Major Funding Rounds | In the fast-paced world of technology and healthcare, two companies have recently made headlines by securing significant funding. Distru, a cannabis industry ERP platform, and Cortechs.ai, a pioneer in AI-powered medical imaging, are both p... |
| 21.11.2024 | Cortechs.ai: Funding Round Raised To Transform AI-Based Neuroimaging And Oncology Solutions | Cortechs.ai, a leader in AI-based neuroimaging and prostate imaging solutions, announced the closing of an oversubscribed Series C funding round led by VILAS Ventures. And existing investor Genting Berhad participated in the round as well. ... |
| 20.11.2024 | Distru Raises $6M in Series A Funding | Distru, an Oakland, CA-based cannabis industry’s ERP platform provider, raised $6M in Series A funding. Backers included Global Founders Capital. The company intends to use the funds to accelerate growth and product development. While alrea... |
| 20.11.2024 | Cortechs.ai Closes Series C Funding | Cortechs.ai, a San Diego, CA-based company which specializes in AI-powered neuroimaging and prostate imaging solutions, announced the close of a Series C funding. The round led by VILAS Ventures. The company intends to use the funds to acce... |